HIMS
Hims & Hers Health, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$28.81
+4.73%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
ValuationView details →
P/E (Fwd)
142.9x
EV/EBITDA
−97.2x
Market Cap
$6.72B
MomentumView details →
1D Return
+4.73%
YTD Return
−9.95%
RSI (14)
49.5
ValuationView details →
P/E (Fwd)
142.9x
EV/EBITDA
−97.2x
Market Cap
$6.72B
RSI (14)
49.5
MomentumView details →
1D Return
+4.73%
YTD Return
−9.95%
SummaryUpdated Jun 1, 2026
Hims & Hers Health, Inc. (NYSE:HIMS) is a San Francisco-based telehealth company that operates a multi-specialty digital health platform connecting consumers directly to licensed healthcare professionals. Founded in 2017, the company went public in 2019 and has rapidly expanded from its initial focus on men's sexual health to become a comprehensive telehealth provider serving over 2.4 million subscribers across multiple health specialties including weight management, dermatology, mental health, and sexual wellness.
Similar companies
Latest newsMore news →
Hims & Hers Health Inc stock rose 6.6% to trade at $29.34.8h agoRobbins LLP announced a class action filed on behalf of investors who purchased Hims & Hers Health, Inc. securities between August 4, 2025 and July 29, 2026, alleging the company shared customers' protected information with advertising platforms and engaged in deceptive advertising practices.10h agoKaplan Fox & Kilsheimer LLP announced that a class action lawsuit has been filed against Hims & Hers Health, Inc. on behalf of investors who acquired its securities between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026.4d ago